Mounting Evidence for Prediagnostic Use of Statins in Reducing Risk of Lethal Prostate Cancer

Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's Letter to the Editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association Between Use of β-Blockers and Prostate Cancer–Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007

(2013) Helene Hartvedt Grytli et al.   EUROPEAN UROLOGY

The Time Is Ripe for a Randomized Trial of Metformin in Clinically Localized Prostate Cancer

(2013) Kathryn L. Penney et al.   JOURNAL OF CLINICAL ONCOLOGY

Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes

(2013) David Margel et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of Statins and the Risk of Death in Patients With Prostate Cancer

(2013) Oriana Yu et al.   JOURNAL OF CLINICAL ONCOLOGY

Statin Use in Relation to Prostate Cancer Outcomes in a Population-based Patient Cohort Study

(2013) Milan S. Geybels et al.   PROSTATE

Statin Use and Reduced Cancer-Related Mortality

(2012) Sune F. Nielsen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy

(2012)   PLoS One

Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies

(2012) Dipika Bansal et al.   PLoS One